| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0190-9622(99)70525-6 |
| P698 | PubMed publication ID | 9922009 |
| P2093 | author name string | Kossard S | |
| Ong CS | |||
| Keogh AM | |||
| Macdonald PS | |||
| Spratt PM | |||
| P2860 | cites work | Trends in non-melanocytic skin cancer treated in Australia: the second national survey | Q42510047 |
| Verapamil inhibition of lymphocyte proliferation and function in vitro | Q43838507 | ||
| A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study | Q46405231 | ||
| Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. | Q53541015 | ||
| Increased Prevalence of Dysplastic and Malignant Lip Lesions in Renal-Transplant Recipients | Q57168859 | ||
| Metastases from Squamous Cell Carcinoma of the Skin in Southern Australia | Q57265937 | ||
| The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine | Q68469214 | ||
| Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice | Q69251683 | ||
| Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine | Q69304473 | ||
| Photochemical sensitization by azathioprine and its metabolites--II. Azathioprine and nitroimidazole metabolites | Q69499667 | ||
| Skin cancer and immunosuppression | Q70033555 | ||
| Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice | Q70037080 | ||
| Risk factors of squamous cell carcinoma of the skin. A case-control study in the Montreal region | Q70048773 | ||
| Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia | Q70199407 | ||
| A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients | Q70522673 | ||
| The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study | Q71015106 | ||
| Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation | Q73279564 | ||
| Skin cancer in a Queensland population. | Q34169827 | ||
| EXPERIMENTAL TOBACCO CARCINOGENESIS. | Q35493116 | ||
| Biology of cutaneous squamous cell carcinoma | Q36745481 | ||
| Squamous cell carcinoma in southern and northern Australia | Q38958826 | ||
| Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group | Q39031896 | ||
| Malignant melanoma in renal-transplant recipients | Q40084271 | ||
| Skin cancer in heart transplant recipients | Q40600620 | ||
| Cutaneous manifestations and consequences of smoking | Q40987294 | ||
| Metastases in Dermatological Patients With Squamous Cell Carcinoma | Q41665111 | ||
| Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects | Q41684992 | ||
| Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia | Q42437654 | ||
| Cutaneous complications in immunosuppressed renal homograft recipients | Q42438248 | ||
| HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas. | Q42460561 | ||
| Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group | Q42460991 | ||
| Skin Cancers and HLA Frequencies in Renal Transplant Recipients | Q42462147 | ||
| On a Possible Protective Effect of HLA-A11 Against Skin Cancer and Keratotic Skin Lesions in Renal Transplant Recipients | Q42462754 | ||
| Relation between skin cancer and HLA antigens in renal-transplant recipients | Q42471887 | ||
| Multiple basal cell carcinomas and HLA frequencies in southern Australia | Q42476383 | ||
| Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia | Q42477194 | ||
| Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation | Q42480931 | ||
| HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer | Q42509988 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | skin cancer | Q192102 |
| P304 | page(s) | 27-34 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Skin cancer in Australian heart transplant recipients | |
| P478 | volume | 40 |
| Q52859211 | A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. |
| Q42440617 | Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution |
| Q44216189 | Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation |
| Q46946071 | Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. |
| Q37460839 | Cohort profile: the skin cancer after organ transplant study |
| Q36334062 | Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs |
| Q45083617 | Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. |
| Q36419678 | Current views on the role of human papillomaviruses in cutaneous oncogenesis |
| Q36311279 | Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia |
| Q36390995 | Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. |
| Q37277272 | Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. |
| Q37779991 | Dermatopathology of skin cancer in solid organ transplant recipients |
| Q49906563 | Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population |
| Q36582021 | Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation |
| Q92312741 | HLA alleles in renal transplant recipients with nonmelanoma skin cancer in southeastern Brazil |
| Q34252626 | Hand transplantation: a current perspective |
| Q36644873 | Hand transplantation: the state-of-the-art |
| Q42501628 | High rejection score in the first year and risk of skin cancer in heart transplantation. |
| Q33880261 | Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort |
| Q34896166 | In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype |
| Q42478812 | Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. |
| Q33918427 | Incidence of and risk factors for skin cancer after heart transplant |
| Q42492822 | Incidence of skin cancer in 5356 patients following organ transplantation |
| Q39021344 | Interleukin-22 and Cyclosporine in Aggressive Cutaneous Squamous Cell Carcinoma. |
| Q40731379 | Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression. |
| Q34066181 | Management of high-risk cutaneous squamous cell carcinoma |
| Q34073976 | Modern approaches to photoprotection |
| Q56828446 | Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma |
| Q73489827 | Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma |
| Q56828372 | Neoplasms |
| Q74266955 | Nonmelanoma skin cancer |
| Q42502317 | Occupational syncarcinogenesis in the skin - combined effects of two carcinogens from the German occupational disease list |
| Q38228585 | Optimal management of skin cancer in immunosuppressed patients |
| Q36381533 | Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey |
| Q34243532 | Retinoid chemoprevention in patients at high risk for skin cancer. |
| Q42526547 | Risk factors associated with the development of skin cancer after liver transplantation |
| Q42515837 | Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. |
| Q46372278 | Sirolimus: a potential chemopreventive agent |
| Q37432717 | Skin cancer after transplantation |
| Q46117898 | Skin cancer and the solid organ transplant recipient |
| Q42470631 | Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations |
| Q63369190 | Skin cancer in heart transplant recipients: frequency and risk factor analysis |
| Q42501633 | Skin diseases following organ transplantation--risk factors and new therapeutic approaches |
| Q43855889 | Skin tumors in organ-transplant recipients |
| Q103031659 | Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients |
| Q42214568 | Squamous cell carcinomas in situ arising in seborrheic keratoses: an association with concomitant immunosuppression? |
| Q35936988 | The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. |
| Q37327170 | The development of squamous cell carcinoma in a patient after kidney transplantation: a case report |
| Q42439568 | The therapy of virus-associated epithelial tumors of the face and the lips in organ transplant recipients |
| Q34964807 | Vitamin D and skin cancer |
| Q36480011 | Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. |
| Q73829667 | [Skin cancer in patients submitted to organ transplantation: a growing problem] |
Search more.